Generic Drug Application Yields Patent Complaint In Delaware Federal Court
(January 22, 2021, 10:44 AM EST) -- WILMINGTON, Del. — Amgen Inc., maker of the chronic heart failure (CHF) drug Corlanor, levied allegations of patent infringement against the filers of an abbreviated new drug application (ANDA) in a...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login